Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease

Advances in Applied Microbiology

Volumn 72, Issue C, 2010, Pages 63-87

  Abratt, Valerie R ^a   Reid, Sharon J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBOXYLYASE; COENZYME A TRANSFERASE; FORMYL COENZYME A TRANSFERASE; OXADROP; OXALYL COENZYME A DECARBOXYLASE; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BIFIDOBACTERIUM; CALCIUM OXALATE STONE; CATABOLISM; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; EGGERTHELLA LENTA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GENE LOCUS; GENETIC CODE; GENETIC ORGANIZATION; HOMEOSTASIS; HUMAN; HYPEROXALURIA; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS; MICROBIAL DEGRADATION; NEPHROLITHIASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXALOBACTER FORMIGENES; PHYLOGENY; PROVIDENCIA RETTGERI; REDUCTION; SPECIES DIFFERENCE; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; LACTOBACILLUS; OXALOBACTER FORMIGENES;

EID: 77954283084     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2164(10)72003-7     Document Type: Chapter

References (74)

1. Abe K., Ruan Z., Malone P.C. Cloning, sequencing, and expression of OxlT, the oxalate:formate exchange protein of Oxalobacter formigenes. J. Biol. Chem. 1996, 271:6789-6793.
2. Allison M.J., Dawson K.A., Mayberry W.R., Foss J.G. Oxalobacter formigenes gen. Nov., sp. nov.: Oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch. Microbiol. 1985, 141:1-7.
3. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
4. Anantharam V., Allison M.J., Maloney P.C. Oxalate:formate exchange. The basis for energy coupling in Oxalobacter. J. Biol. Chem. 1989, 264:7244-7250.
5. Azcarate-Peril M.A., Bruno-Barcena J.M., Hassan H.M., Klaenhammer T.R. Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. Appl. Environ. Microbiol. 2006, 72:1891-1899.
6. Azcarate-Peril M.A., Altermann E., Goh Y.J., Tallon R., Sanozky-Dawes R.B., Pfeiler E.A., O'Flaherty S., Buck B.L., Dobson A., Duong T., Miller M.J., Barrangou R., Klaenhammer T.R. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl. Environ. Microbiol. 2008, 74:4610-4625.
7. Baetz A.L., Allison M.J. Purification and characterization of formyl-coenzyme A transferase from Oxalobacter formigenes. J. Bacteriol. 1990, 172:3537-3540.
8. Baker P.W., Coyle P., Bais R., Rofe A.M. Influence of season, age, and sex on renal stone formation in South Australia. Med. J. Aust. 1993, 20:390-392.
9. Campieri C., Campieri M., Bertuzzi V., Swennen E., Mateeuzzi D., Stefoni S., Pirovano F., Centi C., Ulisse S., Famularo G., De Simone C. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int. 2001, 60:1097-1105.
10. Castillo M., Martín-Orúe S.M., Manzanilla E.G., Badiola I., Martín M., Gasa J. Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-time PCR. Vet. Microbiol. 2006, 114:165-170.
11. 2 by Oxalobacter formigenes. Can. J. Microbiol. 1996, 42:1081-1086.
12. Delroisse J.M., Boulvin A.L., Parmentier I., Dauphin R.D., Vandenbol M., Portetelle D. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol. Res. 2008, 163:663-670.
13. Duffey B.G., Pedro R.N., Makhlouf A., Kriedberg C., Stessman M., Hinck B., Ikramuddin S., Kellogg T., Slusarek B., Monga M. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J. Am. Coll. Surg. 2008, 206:1145-1153.
14. Duncan S.H., Richardson A.J., Kaul P., Holmes R.P., Allison M.J., Stewart C.S. Oxalobacter formigenes and its potential role in human health. Appl. Environ. Microbiol. 2002, 68:3841-3847.
15. Fan J., Chandhoke P.S., Grampas S.A. Role of sex hormones in experimental calcium oxalate nephrolithiasis. J. Am. Soc. Nephrol. 1999, 10(Suppl. 14):S376-S380.
16. Federici F., Vitali B., Gotti R., Pasca M.R., Gobbi S., Peck A.B., Brigidi P. Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl. Environ. Microbiol. 2004, 70:5066-5073.
17. Ferraz R.B.N., Marques N.C., Froeder L., Menon V.B., Siliao P.R., Baxmann A.C., Heilberg I.P. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients. Urol. Res. 2009, 37:95-100.
18. Foster J.W. Escherichia coli acid resistance: Tales of an amateur acidophile. Nat. Rev. Microbiol. 2004, 2:898-907.
19. Goldfarb D.S., Modersitzki F., Asplin J.R. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin. J. Am. Soc. Nephrol. 2007, 2:745-749.
20. Gruez A., Roig-Zamboni V., Valencia C., Campanacci V., Cambillau C. The crystal structure of the Escherichia coli YfdW gene product reveals a new fold of two interlaced rings identifying a wide family of CoA transferases. J. Biol. Chem. 2003, 278:34582-34586.
21. Hall P.M. Nephrolithiasis: Treatment, causes, and prevention. Cleve. Clin. J. Med. 2009, 76:583-591.
22. Hanson K. Urinary stones and Crohn's disease. Urol. Nurs. 2005, 25:466-468.
23. Harold F.C., Maloney P.C. Energy transduction by ion currents. Escherichia coli and Salmonella, Vol. 1 1996, 300-301. AMS Press, Washington, DC. 2nd edn. F.C. Neidhardt (Ed.).
24. Hatch M., Freel R.W. The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin. Nephrol. 2008, 28:143-151.
25. Hatch M., Freel R.W., Vaziri N.D. Characteristics of the transport of oxalate and other ions across rabbit proximal colon. Pflugers Arch. 1993, 423:206-212.
26. Hesse A., Siener R., Heynek H., Jahnen A. The influence of dietary factors on the risk of urinary stone formation. Scan. Microsc. 1993, 7:1119-1128.
27. Hokama S., Honma Y., Toma C., Ogawa Y. Oxalate-degrading Enterococcus faecalis. Microbiol. Immunol. 2000, 44:235-240.
28. Hokama S., Toma C., Iwanaga M., Morozumi M., Sugaya K., Ogawa Y. Oxalate-degrading Providencia rettgeri isolated from human stools. J. Urol. 2005, 12:533-538.
29. Holmes R.P., Assimos D.G. Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J. Urol. 1998, 160:1617-1624.
30. Holmes R.P., Kennedy M. Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int. 2000, 57:1662-1667.
31. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22:283-307.
32. Hoppe B., Beck B., Gatter N., von Unruh G., Tischer A., Hesse A., Laube N., Kaul P., Sidhu H. Oxalobacter formigenes: A potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int. 2007, 70:1305-1311.
33. Hoppe B., Beck B.B., Milliner D.S. The primary hyperoxalurias. Kidney Int. 2009, 75:1264-1271.
34. Hugenholtz P., Goebel B.M., Pace N.R. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J. Bacteriol. 1998, 180:4765-4774.
35. Iapichino G., Callegari M.L., Marzorati S., Cigada M., Corbella D., Ferrari S., Morelli L. Impact of antibiotics on the gut microbiota of critically ill patients. J. Med. Microbiol. 2008, 57:1007-1014.
36. Ito H., Kotake T., Masai M. In vitro degradation of oxalic acid by human faeces. Int. J. Urol. 1996, 3:207-211.
37. Ito H., Miura N., Masai M., Yanamoto K., Hara T. Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1. Int. J. Urol. 1996, 3:31-34.
38. Knight J., Holmes R.P., Assimos D.G. Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol. Res. 2007, 35:111-117.
39. Kodama T., Akakura K., Mikami K., Ito H. Detection and identification of oxalate-degrading bacteria in human faeces. Int. J. Urol. 2002, 9:392-397.
40. Kuhner C.H., Hartman P.A., Allison M.J. Generation of a proton motive by the anaerobic oxalate-degrading bacterium Oxalobacter formigenes. Appl. Env. Microbiol. 1996, 62:2494-2500.
41. Kwak C., Jeong B.C., Lee J.H., Kim H.K., Kim E.C., Kim H.H. Molecular identification of Oxalobacter formigenes with the polymerase chain reaction in fresh or frozen fecal samples. BJU Int. 2001, 88:627-632.
42. Kwak C., Jeong B.C., Ku J.H., Kim H.H., Lee J.J., Huh C.S., Baek Y.J., Lee S.E. Prevention of nephrolithiasis by Lactobacillus in stone-forming rats: A preliminary study. Urol. Res. 2006, 34:265-270.
43. T degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota. FEMS Microbiol. Ecol. 2007, 61:110-120.
44. Liebman M., Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J. Urol. 2000, 163:1565-1569.
45. Lieske J.C., Goldfarb D.S., De Simone C., Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int. 2005, 68:1244-1249.
46. Lung H.Y., Cornelius J.G., Peck A.B. Cloning and expression of the oxalyl-CoA decarboxylase gene from the bacterium. Oxalobacter formigenes: Prospects for gene therapy to control Ca-oxalate kidney stone formation. Am. J. Kidney Dis. 1991, 17:381-385.
47. Lung H.-Y., Baetz A.L., Peck A.B. Molecular cloning, DNA sequence and gene expression of the oxalyl-coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes. J. Bacteriol. 1994, 176:2468-2472.
48. Macfarlane S., Macfarlane G.T. Bacterial diversity in the human gut. Adv. Appl. Microbiol. 2004, 54:261-289.
49. Massey L.K., Roman-Smith H., Sutton R.A. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J. Am. Diet Assoc. 1993, 93:901-906.
50. Nadler R.B., Rubenstein J.N., Eggener S.E., Loor M.M., Smith N.D. The etiology of urolithiasis in HIV infected patients. J. Urol. 2003, 169:475-477.
51. Ochman H., Lawrence J.G., Groisman E.A. Lateral gene transfer and the nature of bacterial innovation. Nature 2000, 405:299-304.
52. Prokopovich S., Knight J., Assimos D.G., Holmes R.P. Variability of Oxalobacter formigenes and oxalate in stool samples. J. Urol. 2007, 178:2186-2190.
53. Rodgers A.L., Lewandowski S. Effects of 5 different diets on urinary risk factors for calcium oxalate kidney stone formation: Evidence of different renal handling mechanisms in different race groups. J. Urol. 2002, 168:931-936.
54. Ruan Z., Anantharam V., Crawford I.T., Ambudkar S.V., Rhee S.Y., Allison M.J., Maloney P.C. Identification, purification, and reconstitution of OxlT, the oxalate:formate antiport protein of Oxalobacter formigenes. J. Biol. Chem. 1992, 267:10537-10543.
55. Sahin N. Oxalotrophic bacteria. Res. Microbiol. 2003, 154:399-407.
56. Schwiertz A., Le Blay G., Blaut M. Quantification of different Eubacterium species with species-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 2000, 66:375-382.
57. Sidhu H., Enastska L., Ogden S., Williams W.N., Allison M.J., Peck A.B. Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reaction detection system. Mol. Diagn. 1997, 2:89-97.
58. Sidhu H., Ogden S.D., Lung H., Luttge B.G., Baetz A.L., Peck A.B. DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes. J. Bacteriol. 1997, 179:3378-3381.
59. Sidhu H., Hoppe B., Hesse A., Tenbrock K., BrÖmme S., Rietchel E., Peck A.B. Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 1998, 352:1026-1029.
60. Sidhu H., Holmes R.P., Allison M.J., Peck A.B. Direct quantification of the enteric bacterium Oxalobacter formigenes in human faecal samples by quantitative competitive template PCR. J. Clin. Microbiol. 1999, 37:1503-1509.
61. Sidhu H., Schmidt M.E., Cornelius J.G., Thamilselvan S., Khan S.R., Hesse A., Peck A.B. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract dwelling bacterium Oxalobacter formigenes: Possible prevention by gut recolonization or enzyme replacement therapy. J. Am. Soc. Nephrol. 1999, (Suppl. 14):S334-S340.
62. Sidhu H., Allison M.J., Chow J.M., Clark A., Peck A.B. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J. Urol. 2001, 166:1487-1491.
63. Siener R., Schade N., Nicolay C., von Unruh G.E., Hesse A. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J. Urol. 2005, 173:1601-1605.
64. Siva S., Barrack E.R., Reddy G.P.V., Thamilselvan V., Thamilselvan S., Menon M., Bhandari M. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int. 2008, 103:18-21.
65. Stewart C.S., Duncan S.H., Cave D.R. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol. Lett. 2004, 230:1-7.
66. Suau A., Bonnet R., Sutren M., Godon J.J., Gibson G.R., Collins M.D., Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 1999, 65:4799-4807.
67. Taylor E.N., Curhan G.C. Role of nutrition in the formation of calcium-containing kidney stones. Nephron. Physiol. 2004, 98:55-63.
68. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
69. Toyota C.G., Berthold C.L., Gruez A., Jónsson S., Lindqvist Y., Cambillau C., Richards N.G. Differential substrate specificity and kinetic behavior of Escherichia coli YfdW and Oxalobacter formigenes formyl coenzyme A transferase. J. Bacteriol. 2008, 190:2556-2564.
70. Turroni S., Vitali B., Bendazzoli C., Candela M., Gotti R., Federici F., Pirovano F., Brigidi P. Oxalate consumption by lactobacilli: Evaluation of oxalyl-CoA decarboxylase and formyl-CoA trenasferase activity in Lactobacillus acidophilus. J. Appl. Microbiol. 2007, 103:1600-1609.
71. Van Driessche L., Dhondt A., De Sutter J. Heart failure with mitral valve regurgitation due to primary hyperoxaluria type 1: Case report with review of the literature. Acta Cardiol. 2007, 62:202-206.
72. Ward D.M., Weller R., Bateson M.M. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature 1990, 345:63-65.
73. Webb M.A. Cell-mediated crystallization of calcium oxalate in plants. Plant Cell 1999, 11:751-761.
74. Wolf B.W., Wheeler K.B., Ataya D.G., Garleb K.A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 1998, 36:1085-1094.